loading

Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.11%
28.03
23.15 18.67 15.89 16.96
Operating Income/Loss
21.11%
-28.03
-23.15 -18.67 -15.89 -16.96
Income/Loss From Continuing Operations Before Tax
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Net Income/Loss
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
199.19%
1.1681
-1.1775 -1.7849 - 4.1304
Basic Earnings Per Share
8.51%
-0.51
-0.47 -0.37 -0.37 -0.45
Diluted Earnings Per Share
8.51%
-0.51
-0.47 -0.37 -0.37 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):